Nos Commanditaires : IRIC 16 avril, 2014 19h00 Salle S1-151 Pavillon Jean-Coutu Université de Montréal.

Slides:



Advertisements
Similar presentations
1 BioSystems International Lung Cancer Biomarker Test February 25th
Advertisements

Protein Quantitation II: Multiple Reaction Monitoring
Protein Quantitation II: Multiple Reaction Monitoring
The Proteomics Core at Wayne State University
Micromass Quattro Ultima triple quadrupole mass spectrometric detector HPLC system (LC) Electrospray ionisation source (-ve & +ve ion) Photodiode array.
Immunity & Infection Research Centre Better Biomarkers in Transplantation. A Genome Canada Initiative for Human Health Rob McMaster, Gabriela Cohen-Freue,
Nos Commanditaires : IRIC 18 mars, h00 Salle S1-151 Pavillon Jean-Coutu Université de Montréal.
UC Mass Spectrometry Facility & Protein Characterization for Proteomics Core Proteomics Capabilities: Examples of Protein ID and Analysis of Modified Proteins.
Sino-Danish Breast Cancer Research Centre Beijing Genomic Institute, Shenzhen University of Copenhagen University of Århus University of Southern Denmark.
Presenter Anna Daily Ph.D.-Senior Scientist March 9, 2012 Breast Health Providers Conference.
MS of Intact Complexes and Hybrid Technologies
Strategic Center for Clinical Cancer Research Clinical Cancer Research using Emerging Advanced Technologies for Health Title Slide.
Quantitative Protein Analysis of CYP450 Induction via LC-MRM Analysis.
Proteomic, Metabolomic and Lipidomic Research Capability at ICH and ION UCL Label Free Quantitative Proteomics “biomarker discovery”
Proteomics Informatics (BMSC-GA 4437) Course Director David Fenyö Contact information
Proteomics Understanding Proteins in the Postgenomic Era.
Proteomics Josh Leung Biology 1220 April 13 th, 2010.
Proteomics Informatics (BMSC-GA 4437) Course Director David Fenyö Contact information
MRMPilot ™ Software © 2008 Applera Corporation and MDS Inc.
NCI’s Clinical Proteomic Technologies for Cancer: “Restructuring Proteomics to Succeed in Discovering Cancer Biomarkers” Joe.
Experimental Design and Biospecimens David F. Ransohoff, MD Division of Gastroenterology and Hepatology; Dept. of Medicine.
Luděk Bláha, PřF MU, RECETOX BIOMARKERS AND TOXICITY MECHANISMS 13 – BIOMARKERS Summary and final notes.
Isolation of N-linked glycopeptides from plasma Yong Zhou 1, Ruedi Aebersold 2, and Hui Zhang 1,3 * 1 Institute for Systems Biology, Seattle, Washington.
Simoa Accelerator Laboratory
Mass spectrometry and mummies Professor Paul A. Haynes Biomolecular Frontiers Research Centre Department of Chemistry and Biomolecular Sciences Macquarie.
Pharmaceutical analysis Bioavailability studies Drug metabolism studies, pharmacokinetics Characterization of potential drugs Drug degradation product.
es/by-sa/2.0/. Large Scale Approaches to the Study of Protein Levels and Activity Prof:Rui Alves
Bringing Metrology to Clinical Proteomic Research David Bunk Chemical Science and Technology Laboratory National Institute of Standards and Technology.
Finish up array applications Move on to proteomics Protein microarrays.
BIOMARKERS Diagnostics and Prognostics. OMICS Molecular Diagnostics: Promises and Possibilities, p. 12 and 26.
Diagnostics Alan S. Rudolph PhD MBA Chief Executive Officer Adlyfe Inc. Rockville, MD Innovation is in our blood Diagnostics.
Quantification of Membrane and Membrane- Bound Proteins in Normal and Malignant Breast Cancer Cells Isolated from the Same Patient with Primary Breast.
Biochemistry 412 February 24 th, 2002, Lecture Biological Mass Spectrometry.
Determination of Total Serum Proteins By Biuret Method
Decoding the Network Footprint of Diseases With increasing availability of data, there is significant activity directed towards correlating genomic, proteomic,
A general method for screening of peptidomimetic libraries by ELISA based tyrosine kinase assay Gy. Bökönyi 1, E. Schäfer 2, E. Várkondi 2, Edit Z. Szabó.
Introduction to Biostatistics and Bioinformatics Experimental Design.
Overview of Mass Spectrometry
© Copyright 2009 by the American Association for Clinical Chemistry Plasma Renin Activity by Liquid Chromatography– Tandem Mass Spectrometry (LC-MS/MS):
Nos Commanditaires : IRIC 18 fevrier, h00 Salle S1-151 Pavillon Jean-Coutu Université de Montréal.
Click to add Text Sample Preparation for Mass Spectrometry Sermin Tetik, PhD Marmara University July 2015, New Orleans.
NCode TM miRNA Analysis Platform Identifies Differentially Expressed Novel miRNAs in Adenocarcinoma Using Clinical Human Samples Provided By BioServe.
Start slide microRNA ISH in FFPE tissue protocol optimization and diagnostic use Seminar by Charlotte B. Ahler, Senior Scientist.
Proteomics Informatics (BMSC-GA 4437) Course Directors David Fenyö Kelly Ruggles Beatrix Ueberheide Contact information
LC separation and MS of histone tryptic peptides allow for their post-translational modification quantitation -For most K residues our histone assay, we.
What is proteomics? Richard Mbasu and Ben Richards.
Biochemical and genetic evaluation in amyloidosis
Results Protein Removal is shown in the silver stained SDS-PAGE gel in Figure 3 below: F IGURE 3: A 10% SDS-PAGE gel after silver staining showing the.
Target Analyses in Parallel Reaction Monitoring Mode (PRM)
Custom peptide synthesis services In the quantitative proteomics research, several MS-based methodologies for relative quantification have been introduced.
Custom peptide synthesis services In the quantitative proteomics research, several MS-based methodologies for relative quantification have been introduced.
Shotgun protein identification Creative Proteomics offers iTRAQ protein quantification service suited for unbiased untargeted biomarker discovery. Relative.
Organellar Proteomics: Turning Inventories into Insights
Richard Mbasu and Ben Richards
David Janz and Lucy Kapronczai
Mass Spectrometry Vs. Immunoassay
Konstantinos Thalassinos
Translational Research Laboratory
Volume 85, Issue 4, Pages (April 2014)
Thomas BOTZANOWSKI & Blandine CHAZARIN
Jesse C. Seegmiller, John H. Eckfeldt, John C. Lieske 
V. Protein Chips 1. What is Protein Chips 2. How to Make Protein Chips
Kenneth Song, Samir Hanash  Gastroenterology 
Proteomic Approaches to Cancer Biomarkers
Volume 25, Issue 3, Pages (March 2017)
Volume 85, Issue 4, Pages (April 2014)
Schematic of AIMS-to-MRM experiment.
Presentation transcript:

Nos Commanditaires : IRIC 16 avril, h00 Salle S1-151 Pavillon Jean-Coutu Université de Montréal

IRIC 16 avril, h00 Salle S1-151 Pavillon Jean-Coutu Université de Montréal Christoph H. Borchers Full Professor, University of Victoria Director, UVic Genome BC Proteomics Centre Novel Approaches in Quantitative and Structural Proteomics for Clinical Research and Diagnostics Protein quantitation is essential for screening biomarker candidates for disease stratification and monitoring, and to verify and validate these biomarkers. Accurate plasma protein concentrations can be determined through a targeted, multiplexed approach involving Multiple Reaction Monitoring (MRM), in conjunction with stable isotope-labeled standard (SIS) peptides. To improve the robustness of MRMs toward the analysis of thousands of patient samples, we have developed assays using standard-flow UPLC/MRM-MS for quantitating multiple proteins (>100) in undepleted human specimen including plasma, urine and CSF. Recent developments in the modern mass spectrometry of proteins and peptides have resulted in significant progress in structural proteomics techniques for studying protein structure. A variety of protein structural questions, ranging from defining protein interaction networks to the study of conformational changes and the structure of single proteins, can be addressed using multiple mass spectrometry based structural proteomics approaches. Each technique provides specific structural information which can be used as experimental structural constraints in protein-structure modeling. Here, we describe recent developments in limited proteolysis, surface modification, hydrogen-deuterium exchange, ion mobility, and crosslinking -- all combined with modern mass spectrometric techniques -- for studying the structure of clinical relevant proteins like prion..

Our Sponsors: IRIC April 16, h00 Room S1-151 Pavillon Jean-Coutu Université de Montréal

IRIC April 16, h00 Room S1-151 Pavillon Jean-Coutu Université de Montréal Christoph H. Borchers Full Professor, University of Victoria Director, UVic Genome BC Proteomics Centre Novel Approaches in Quantitative and Structural Proteomics for Clinical Research and Diagnostics Protein quantitation is essential for screening biomarker candidates for disease stratification and monitoring, and to verify and validate these biomarkers. Accurate plasma protein concentrations can be determined through a targeted, multiplexed approach involving Multiple Reaction Monitoring (MRM), in conjunction with stable isotope-labeled standard (SIS) peptides. To improve the robustness of MRMs toward the analysis of thousands of patient samples, we have developed assays using standard-flow UPLC/MRM-MS for quantitating multiple proteins (>100) in undepleted human specimen including plasma, urine and CSF. Recent developments in the modern mass spectrometry of proteins and peptides have resulted in significant progress in structural proteomics techniques for studying protein structure. A variety of protein structural questions, ranging from defining protein interaction networks to the study of conformational changes and the structure of single proteins, can be addressed using multiple mass spectrometry based structural proteomics approaches. Each technique provides specific structural information which can be used as experimental structural constraints in protein-structure modeling. Here, we describe recent developments in limited proteolysis, surface modification, hydrogen-deuterium exchange, ion mobility, and crosslinking -- all combined with modern mass spectrometric techniques -- for studying the structure of clinical relevant proteins like prion..